Your browser doesn't support javascript.
loading
Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration.
Wilman, Henry R; Parisinos, Constantinos A; Atabaki-Pasdar, Naeimeh; Kelly, Matt; Thomas, E Louise; Neubauer, Stefan; Mahajan, Anubha; Hingorani, Aroon D; Patel, Riyaz S; Hemingway, Harry; Franks, Paul W; Bell, Jimmy D; Banerjee, Rajarshi; Yaghootkar, Hanieh.
Afiliação
  • Wilman HR; Research Centre for Optimal Health, School of Life Sciences, University of Westminster, London, UK; Perspectum Diagnostics Ltd., Oxford, UK.
  • Parisinos CA; Institute of Health Informatics, Faculty of Population Health Sciences, University College London, London, UK. Electronic address: c.parisinos@ucl.ac.uk.
  • Atabaki-Pasdar N; Department of Clinical Sciences, Genetic and Molecular Epidemiology Unit, Lund University, Skåne University Hospital Malmö, Malmö, Sweden.
  • Kelly M; Perspectum Diagnostics Ltd., Oxford, UK.
  • Thomas EL; Research Centre for Optimal Health, School of Life Sciences, University of Westminster, London, UK.
  • Neubauer S; Perspectum Diagnostics Ltd., Oxford, UK; Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
  • Mahajan A; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Hingorani AD; Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, UK.
  • Patel RS; Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, UK.
  • Hemingway H; Institute of Health Informatics, Faculty of Population Health Sciences, University College London, London, UK.
  • Franks PW; Department of Clinical Sciences, Genetic and Molecular Epidemiology Unit, Lund University, Skåne University Hospital Malmö, Malmö, Sweden.
  • Bell JD; Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
  • Banerjee R; Perspectum Diagnostics Ltd., Oxford, UK.
  • Yaghootkar H; Research Centre for Optimal Health, School of Life Sciences, University of Westminster, London, UK; Genetics of Complex Traits, College of Medicine and Health, University of Exeter, Exeter, UK. Electronic address: h.yaghootkar@exeter.ac.uk.
J Hepatol ; 71(3): 594-602, 2019 09.
Article em En | MEDLINE | ID: mdl-31226389
ABSTRACT
BACKGROUND &

AIMS:

Excess liver iron content is common and is linked to the risk of hepatic and extrahepatic diseases. We aimed to identify genetic variants influencing liver iron content and use genetics to understand its link to other traits and diseases.

METHODS:

First, we performed a genome-wide association study (GWAS) in 8,289 individuals from UK Biobank, whose liver iron level had been quantified by magnetic resonance imaging, before validating our findings in an independent cohort (n = 1,513 from IMI DIRECT). Second, we used Mendelian randomisation to test the causal effects of 25 predominantly metabolic traits on liver iron content. Third, we tested phenome-wide associations between liver iron variants and 770 traits and disease outcomes.

RESULTS:

We identified 3 independent genetic variants (rs1800562 [C282Y] and rs1799945 [H63D] in HFE and rs855791 [V736A] in TMPRSS6) associated with liver iron content that reached the GWAS significance threshold (p <5 × 10-8). The 2 HFE variants account for ∼85% of all cases of hereditary haemochromatosis. Mendelian randomisation analysis provided evidence that higher central obesity plays a causal role in increased liver iron content. Phenome-wide association analysis demonstrated shared aetiopathogenic mechanisms for elevated liver iron, high blood pressure, cirrhosis, malignancies, neuropsychiatric and rheumatological conditions, while also highlighting inverse associations with anaemias, lipidaemias and ischaemic heart disease.

CONCLUSION:

Our study provides genetic evidence that mechanisms underlying higher liver iron content are likely systemic rather than organ specific, that higher central obesity is causally associated with higher liver iron, and that liver iron shares common aetiology with multiple metabolic and non-metabolic diseases. LAY

SUMMARY:

Excess liver iron content is common and is associated with liver diseases and metabolic diseases including diabetes, high blood pressure, and heart disease. We identified 3 genetic variants that are linked to an increased risk of developing higher liver iron content. We show that the same genetic variants are linked to higher risk of many diseases, but they may also be associated with some health advantages. Finally, we use genetic variants associated with waist-to-hip ratio as a tool to show that central obesity is causally associated with increased liver iron content.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estudo de Associação Genômica Ampla / Hepcidinas / Proteína da Hemocromatose / Hemocromatose / Ferro / Fígado Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estudo de Associação Genômica Ampla / Hepcidinas / Proteína da Hemocromatose / Hemocromatose / Ferro / Fígado Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article